News

Chondroitin Prevented Joint Destruction in Knee OA


 

FROM ANNALS OF THE RHEUMATIC DISEASES

Dr. Jean-Pierre Pelletier and Dr. Johanne Martel-Pelletier are consultants for and shareholders in ArthroLab Inc. and ArthroVision Inc. Jean-Pierre Raynauld is a consultant for ArthroVision. Dr. André Beaulieu, Dr. Louis Bassette, and Dr. Frédéric Morin received honoraria from ArthroLab. François Abram is an employee of ArthroVision. Marc Dorais is a consultant for ArthroVision. Dr. Altman had no relevant financial conflicts of interest.

Pages

Recommended Reading

ACR/EULAR Criteria Define RA Remission
MDedge Family Medicine
Role of ACE Inhibitors in Preventing Scleroderma Renal Crisis Remains Unclear
MDedge Family Medicine
Imaging Study Offers New Insight on RA's Pathology
MDedge Family Medicine
Rule Can Predict Walking Outcomes After Spinal Cord Injury
MDedge Family Medicine
Methotrexate Combination Helps Prolong Anti-TNF Use
MDedge Family Medicine
Now Let Us Mark the Passing of Gold
MDedge Family Medicine
Rheumatologists Are Ready to Play
MDedge Family Medicine
Belimumab's FDA Approval Marks New Lupus-Treatment Era
MDedge Family Medicine
Sildenafil Reduced Attack Frequency in Raynaud's
MDedge Family Medicine
Nazi Taint Sparks Proposed Name Change for Wegener's Granulomatosis
MDedge Family Medicine